super symposium - art of the possible

25
TIDE: Tech Incubation Labs Steve Woodward Super Symposium 2017 June 2017 THE ART OF THE POSSIBLE

Upload: steve-woodward

Post on 21-Jan-2018

60 views

Category:

Technology


1 download

TRANSCRIPT

Page 1: Super Symposium - Art of the possible

TIDE: Tech Incubation Labs

Steve WoodwardSuper Symposium 2017 June 2017

THE ART OF THE POSSIBLE

Page 2: Super Symposium - Art of the possible

2

TECHNOLOGY INCUBATION LAB

Drive Technology

Leadership

• Accelerate innovation

culture

• Support learning between

functional silos

• Position IT as a strategic

partner

Bring Emerging

Technology In

• Reframe problems

• Leverage new

technology to improve

operations

• Exploit new business

opportunities

2 3External

Perspective

• Tech Trends

• Best practice

• Pharma and other

industries

• Potentially disruptive

developments

trends start-ups

VCs presentations

news register

showcase tools

1

scout validate

proof of concepts

Page 3: Super Symposium - Art of the possible

3

TECHNOLOGY INCUBATION LAB

Josh MesoutSolution Engineer

Rapid Prototyping

Innovation

Data & AI

Finance & GPPS

AstraZeneca

A diverse and

multi-disciplinary team

Page 4: Super Symposium - Art of the possible

What Do we

Do?

Page 5: Super Symposium - Art of the possible

5

PROACT

Developed a mobile app to capture patient videos and diaries to understand drug

tolerability and potential side effects in phase 1 clinical trials.

Developed video extraction Text

Developed facial expression Sentiment

Page 6: Super Symposium - Art of the possible

CHAT BOTS INTEGRATIONS

Page 7: Super Symposium - Art of the possible
Page 8: Super Symposium - Art of the possible

8

VIRTUAL ASSISTANTS

1st Version created at a Hackathon

Originally for taking minutes in

meetings

Pivoted to a feedback app and piloted for

Ops 2020

Page 9: Super Symposium - Art of the possible

9

IOT BUTTONS

• Programmable IoT Button

• Interactions• Normal Press

• Long Press

• Double Press

Page 10: Super Symposium - Art of the possible

10

IOT IN SCIENCE AND MANUFACTURING

$500+ million dollar

investment

~1600 AZ & MedImmune

R&D science jobs

>12,000 Healthcare roles

working at CBC

IoT Fundamental to the running of the building

Page 11: Super Symposium - Art of the possible

11

IOT IN SCIENCE AND MANUFACTURING

Monitoring efficiency of our critical processes and

equipment

Page 12: Super Symposium - Art of the possible

12

TRANSLATE API DRIVEN

• Allows high throughput

translation

• No need to understand

source language

• 108 recognised languages

• Enterprise service, not

public so no data is retained

by Google

Page 13: Super Symposium - Art of the possible

13

BLOCKCHAIN

Page 14: Super Symposium - Art of the possible

14

HACKATHONS

Sigma AstraZenecaPebbleCode

Page 15: Super Symposium - Art of the possible

What's Next?

Page 16: Super Symposium - Art of the possible

16

AZ GENOMICS INITIATIVE

Major 10 Year program to

support precision medicine &

digital health

Combine Clinical Patient

data with Genomic data to

drive our R&D pipeline.

Page 17: Super Symposium - Art of the possible

17

DARK WEB INDEXING

Monitoring Dark Web

marketplaces for counterfeit

drugs being sold

Page 18: Super Symposium - Art of the possible

18

HARDWARE PENETRATION TESTING

?

Page 19: Super Symposium - Art of the possible

19

FUTURE HORIZON

Developing regulatory devices for

mixed reality, super secretive

MagicLeap already have a

healthcare division and are looking

for partners

Working with Google, have

simulated a hydrogen molecule

using Quantum Computing. This

provides amazing opportunities in

optimization problems in seconds

Reduced entire infrastructure cost

by >10% using advanced neural

networks. DeepMind now working

with the NHS on differentiating

healthy and cancerous tissues

Page 20: Super Symposium - Art of the possible

20

INGESTIBLES, WEARABLES AND EMBEDDABLES

Page 21: Super Symposium - Art of the possible

How You Can

Be Part Of

Innovation

Page 22: Super Symposium - Art of the possible

22

TECHNOLOGY INNOVATION NETWORK

Technology Innovation Network

AZ Inspire Network

Interaction Network

External Talks

AI Network

Tech Talks

IoT Network

Internal talks showcasing

IT innovation throughout

the company

Early Stage network specializing in connected devices and projects or PoCs

Early stage network specializing in projects that

utilize future interaction methods

Graduate and apprentice network giving exposure and experience to our most innovative generation

Early stage network specializing in projects that

implement machine learning or AI capabilities

Globally identifiable companies who's innovative approach make them thought leaders

Recorded & Available On Nucleus Video

Monthly

Lightening

Talks (5 min)

Page 23: Super Symposium - Art of the possible

23

TECHNOLOGY INNOVATION NETWORK

23

Chris Evans

Development of a AI Chatbot

Logan King

Augmented Reality drug

adherence leaflet in

PharmTech

Frank Lombardi

Adverse events from Veeva

for Commercial using NLP

and translate

Josh Mesout

Facial sentiment

analysis using AI and

image analytics

Daniel Nunn

Swiftstack in Research

& Development

Charley Denny

AZInsight – Gamification

of Clarity forecasting

Apprentices, Interns, Students and Graduates

Page 24: Super Symposium - Art of the possible

24

TECHNOLOGY INNOVATION NETWORK

24

Neil Hardy

GCE

Commercial

SeenIT

Marie Eckerd

Clinical Ops

GMD

Trinetx

Andrew Ashall

Regulatory

GMD

Amazon Alexa

Paul Gellert

PharmDev

Ops

3D printing

Paul Harper

Discovery Sci.

IMED

Lab Robotics

Christoph Grebner

Comp. Chem

IMED

Molecular Rift

Jim Weatherall

Biometrics & Inf.

GMD

Machine Learning

Outside IT TECHTalks >50%

Jon Dry

Oncology Inf.

IMED

Healthpatch

Page 25: Super Symposium - Art of the possible

Confidentiality Notice

This file is private and may contain confidential and proprietary information. If you have received this file in error, please notify us and remove

it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorized use or disclosure of the

contents of this file is not permitted and may be unlawful. AstraZeneca PLC, 1 Francis Crick Avenue, Cambridge Biomedical Campus,

Cambridge, CB2 0AA, UK, T: +44(0)203 749 5000, www.astrazeneca.com

25

Remember we want you to present at future TIN

sessions!

Thank You & Questions!

Steve Woodward [email protected]

Nick Brown [email protected]